Publication | Closed Access

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-α at the translational level

InflammationTranslational MedicineAntifibrotic TherapyFibrosisTranslational BiologyAnti-inflammatoryMedicinePathologyPharmacotherapyAnti-cancer AgentPharmacologyTranslational LevelTumor Necrosis Factor-αTumor Biology